ATE517614T1 - Pflaster enthaltend einen anti-inflammatorischen wirkstoff - Google Patents

Pflaster enthaltend einen anti-inflammatorischen wirkstoff

Info

Publication number
ATE517614T1
ATE517614T1 AT01919982T AT01919982T ATE517614T1 AT E517614 T1 ATE517614 T1 AT E517614T1 AT 01919982 T AT01919982 T AT 01919982T AT 01919982 T AT01919982 T AT 01919982T AT E517614 T1 ATE517614 T1 AT E517614T1
Authority
AT
Austria
Prior art keywords
mass
test
active ingredient
antiinflammatory
molecular weight
Prior art date
Application number
AT01919982T
Other languages
English (en)
Inventor
Yasuhiro Ikeura
Miyuki Shinmura
Original Assignee
Hisamitsu Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hisamitsu Pharmaceutical Co filed Critical Hisamitsu Pharmaceutical Co
Application granted granted Critical
Publication of ATE517614T1 publication Critical patent/ATE517614T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7076—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising ingredients of undetermined constitution or reaction products thereof, e.g. rosin or other plant resins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Botany (AREA)
  • Rheumatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT01919982T 2000-04-18 2001-04-17 Pflaster enthaltend einen anti-inflammatorischen wirkstoff ATE517614T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000116744 2000-04-18
PCT/JP2001/003283 WO2001078690A1 (fr) 2000-04-18 2001-04-17 Piece contenant un agent anti-inflammatoire

Publications (1)

Publication Number Publication Date
ATE517614T1 true ATE517614T1 (de) 2011-08-15

Family

ID=18628168

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01919982T ATE517614T1 (de) 2000-04-18 2001-04-17 Pflaster enthaltend einen anti-inflammatorischen wirkstoff

Country Status (13)

Country Link
US (2) US20030149383A1 (de)
EP (1) EP1277466B1 (de)
JP (1) JP4854163B2 (de)
KR (1) KR100600456B1 (de)
CN (1) CN1200696C (de)
AT (1) ATE517614T1 (de)
BR (1) BR0110178A (de)
CA (1) CA2406261C (de)
DK (1) DK1277466T3 (de)
ES (1) ES2367541T3 (de)
PT (1) PT1277466E (de)
TW (1) TWI283587B (de)
WO (1) WO2001078690A1 (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60033426T2 (de) * 1999-12-15 2007-10-31 Hisamitsu Pharmaceutical Co., Inc., Tosu Adhäsive zubereitungen
FR2838745B1 (fr) * 2002-04-17 2004-07-09 Urgo Laboratoires Emulsions solides a base d'elastomere thermoplastique
AU2003272878A1 (en) * 2002-09-13 2004-04-30 Hisamitsu Pharmaceutical Co., Inc. Adhesive patch
ES2397217T3 (es) 2003-03-18 2013-03-05 Hisamitsu Pharmaceutical Co., Inc. Parche que contiene diclofenaco
TWI327074B (en) * 2003-05-07 2010-07-11 Hisamitsu Pharmaceutical Co Ultra violet shielding patch
US7476222B2 (en) * 2003-06-30 2009-01-13 Johnson & Johnson Consumer Companies, Inc. Methods of reducing the appearance of pigmentation with galvanic generated electricity
BRPI0415652B8 (pt) * 2003-10-20 2021-07-27 Hisamitsu Pharmaceutical Co composição adesiva sensível à pressão
DE10357321A1 (de) * 2003-12-05 2005-07-21 Tesa Ag Hochtackige Klebmasse, Verfahren zu deren Herstellung und deren Verwendung
TWI341736B (en) * 2003-12-26 2011-05-11 Hisamitsu Pharmaceutical Co Anti-infammatory adhesive preparations
WO2006025583A1 (ja) * 2004-08-31 2006-03-09 Aspion Co., Ltd. Ｓ／ｏ型外用剤
EP1815852B1 (de) * 2004-11-05 2017-01-25 Lead Chemical Co. Ltd. Nichtwässrige zubereitung zur perkutanen absorption mit nichtsteroidalem entzündungshemmendem analgetikum
JP4869583B2 (ja) * 2004-11-30 2012-02-08 久光製薬株式会社 角質剥離が少ない貼付剤
JP2006206471A (ja) * 2005-01-26 2006-08-10 Nitto Denko Corp テープ製剤
US20090028806A1 (en) * 2005-02-25 2009-01-29 Shigeo Suzuki Medicine for External Application Containing Anti-Inflammatory Agent and Soy Lecithin
JP5089376B2 (ja) * 2005-03-10 2012-12-05 久光製薬株式会社 粘着剤及び貼付剤
WO2006095820A1 (ja) * 2005-03-10 2006-09-14 Hisamitsu Pharmaceutical Co., Inc. 粘着剤及び貼付剤
US20060263420A1 (en) * 2005-03-10 2006-11-23 Hisamitsu Pharmaceutical Co., Inc. Adhesive and plaster
JP4921739B2 (ja) * 2005-08-10 2012-04-25 久光製薬株式会社 皮膚刺激を低減した貼付剤
JP5684441B2 (ja) * 2005-12-28 2015-03-11 久光製薬株式会社 インドメタシン含有貼付剤
EP2228063B1 (de) * 2007-12-12 2012-02-01 Teikoku Seiyaku Co., Ltd. Loxoprofenhaltiges wässriges pflaster
CN101502499B (zh) * 2009-03-13 2011-07-27 北京化工大学 一种布洛芬经皮释放贴剂及其制备方法
JP5686132B2 (ja) * 2010-04-13 2015-03-18 東亞合成株式会社 医療用粘着剤組成物、医療用貼付剤及び該組成物の製造方法
JP6014813B2 (ja) * 2010-09-03 2016-10-26 株式会社 ケイ・エム トランスダーム 経皮吸収製剤および皮膚貼付用粘着シート
WO2012060376A1 (ja) * 2010-11-02 2012-05-10 帝國製薬株式会社 フェルビナク含有外用貼付剤
CN103849100A (zh) * 2012-12-03 2014-06-11 中国石油化工股份有限公司 一种用于膏药或贴剂的载体苯乙烯-异戊二烯嵌段共聚组合物及胶粘剂的制备
JP5767417B1 (ja) 2015-02-05 2015-08-19 久光製薬株式会社 貼付剤
CN106692110B (zh) * 2015-08-19 2019-12-17 天津市山佳医药科技有限公司 一种芳基丙酸类非甾体抗炎药贴剂及其制备方法
CN106692111A (zh) * 2015-11-13 2017-05-24 北京泰德制药股份有限公司 一种含有酮洛芬的皮肤外用贴剂及其制备方法
CN106822049B (zh) * 2015-12-07 2020-10-20 北京乳凝创智生物技术研发中心（有限合伙） 新型化药贴剂酮洛芬贴片及其制备方法
EP3301133A1 (de) * 2016-09-29 2018-04-04 ARLANXEO Canada Inc. Multimodale polyisoolefinzusammensetzungen und verfahren zu ihrer herstellung
CN109862885A (zh) * 2016-10-18 2019-06-07 Lts勒曼治疗系统股份公司 双层局部治疗系统
US11872320B2 (en) * 2021-02-25 2024-01-16 Hisamitsu Pharmaceutical Co., Inc. Method for treating osteoarthritis
US20230120384A1 (en) * 2021-10-19 2023-04-20 Heather Sloan Menthol- and magnesium-infused kinesiology tape
DE102021128912A1 (de) * 2021-11-05 2023-05-11 Lts Lohmann Therapie-Systeme Ag. Okklusives pflaster mit flexibler backing
CN117159508A (zh) * 2023-09-18 2023-12-05 湖南九典制药股份有限公司 热熔型贴剂及其制备方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4158609A (en) * 1975-09-23 1979-06-19 Mueller Hans Process for the continuous conversion of products by enzyme action
JPS5888334A (ja) * 1981-11-20 1983-05-26 Takasago Corp ３−ｌ−メントキシプロパン−１、２−ジオ−ル
JPS5951215A (ja) 1982-09-14 1984-03-24 Taisho Pharmaceut Co Ltd 粘着性湿布剤
US4895727A (en) * 1985-05-03 1990-01-23 Chemex Pharmaceuticals, Inc. Pharmaceutical vehicles for exhancing penetration and retention in the skin
CH666621A5 (de) * 1986-06-27 1988-08-15 Ciba Geigy Ag Topisch applizierbare pharmazeutische zusammensetzungen mit systemischer wirkung.
JPS6440420A (en) 1987-08-04 1989-02-10 Hisamitsu Pharmaceutical Co Anti-inflammatory and analgesic tape agent for percutaneous administration
US5059189A (en) * 1987-09-08 1991-10-22 E. R. Squibb & Sons, Inc. Method of preparing adhesive dressings containing a pharmaceutically active ingredient
US5750134A (en) * 1989-11-03 1998-05-12 Riker Laboratories, Inc. Bioadhesive composition and patch
SG59962A1 (en) * 1989-11-03 1999-02-22 Riker Laboratories Inc Bioadhersive composition and patch
EP0484543B1 (de) * 1990-04-24 1995-12-13 Teijin Limited Pflaster
US5633192A (en) * 1991-03-18 1997-05-27 Boston University Method for epitaxially growing gallium nitride layers
EP0607434B1 (de) * 1991-08-30 1999-01-27 Hisamitsu Pharmaceutical Co., Inc. Entzündungshemmendes, analgetisches pflaster
JPH05331064A (ja) 1992-05-26 1993-12-14 Sekisui Chem Co Ltd 消炎鎮痛貼付剤
DE4336557C2 (de) * 1993-05-06 1997-07-17 Lohmann Therapie Syst Lts Estradiolhaltiges transdermales therapeutisches System, Verfahren zu seiner Herstellung und seine Verwendung
WO1994026309A1 (en) * 1993-05-19 1994-11-24 Hisamitsu Pharmaceutical Co., Inc. Solubilizing agent and external preparation containing the same
DK0760238T3 (da) * 1994-05-18 2002-07-22 Hisamitsu Pharmaceutical Co Præparat, der kan indgives perkutant, til behandling af vandladningslidelse
KR100191062B1 (ko) * 1994-09-16 1999-06-15 나카토미 히로타카 외용첩부제
JP3908795B2 (ja) * 1994-11-29 2007-04-25 久光製薬株式会社 ケトチフェン含有経皮投与製剤
AU722937B2 (en) 1996-12-06 2000-08-17 Hisamitsu Pharmaceutical Co., Inc. Plaster containing felbinac
KR19990026792A (ko) 1997-09-26 1999-04-15 김윤 디클로페낙 디에틸암모늄염을 함유한 매트릭스형 패취제제
DE60033426T2 (de) * 1999-12-15 2007-10-31 Hisamitsu Pharmaceutical Co., Inc., Tosu Adhäsive zubereitungen
JP2001328935A (ja) * 2000-05-19 2001-11-27 Hisamitsu Pharmaceut Co Inc 貼付剤
BR0111580A (pt) * 2000-06-13 2003-09-16 Hisamitsu Pharmaceutical Co Curativo

Also Published As

Publication number Publication date
CA2406261C (en) 2010-12-07
CN1424908A (zh) 2003-06-18
CN1200696C (zh) 2005-05-11
US20030149383A1 (en) 2003-08-07
CA2406261A1 (en) 2002-10-17
DK1277466T3 (da) 2011-10-17
EP1277466A1 (de) 2003-01-22
EP1277466B1 (de) 2011-07-27
US20090258952A1 (en) 2009-10-15
KR100600456B1 (ko) 2006-07-13
WO2001078690A1 (fr) 2001-10-25
BR0110178A (pt) 2003-12-30
TWI283587B (en) 2007-07-11
KR20020089476A (ko) 2002-11-29
US8173156B2 (en) 2012-05-08
ES2367541T3 (es) 2011-11-04
EP1277466A4 (de) 2008-08-20
PT1277466E (pt) 2011-09-01
JP4854163B2 (ja) 2012-01-18

Similar Documents

Publication Publication Date Title
ATE517614T1 (de) Pflaster enthaltend einen anti-inflammatorischen wirkstoff
PE20030399A1 (es) Formas de administracion de propiverina o sus sales farmaceuticamente aceptables con liberacion prolongada de la sustancia activa
NO20052479L (no) Tramadolformuleringer med forsinket frigjoring og 24 timers effektivitet
EA200901393A1 (ru) Фармацевтическая композиция, содержащая гестагены и/или эстрогены и 5 метил-(6s)-тетрагидрофолат
EA200301165A1 (ru) Лекарственное средство на основе оксикодона
NO20051854L (no) Vedvarende frigivelse opioidformuleringer og fremgangsmater for anvendelse.
DE60232417D1 (de) Opioid-agonist-formulierungen mit freisetzbarem und sequestriertem antagonist
TR200103693T2 (tr) Yeni formülasyon
BG66093B1 (bg) Състави с контролирано освобождаване, съдържащи нимесулид
DK1185253T3 (da) Oralt præparat til indgivelse af en fast kombination af tramadol og diclofenac
BRPI0507735A (pt) composição para administração oral de cloridrato de tamsulosin e formulação de gránulo de liberação controlada compreendendo a mesma
RS50768B (sr) Režim doziranja i farmaceutska formulacija za urgentnu zaštitu
CY1107729T1 (el) Φαρμακευτικες συνθεσεις
NO20073405L (no) Farmasoytisk utforming inneholdende en frigjoringshastighetskontrollerende sammensetning
HUP0104330A2 (hu) EtO2C-CH2-(R)Cgl-Aze-Pab-OH kristályos formái, előállításukra szolgáló eljárás, azokat hatóanyagként tartalmazó gyógyszerkészítmények és alkalmazásuk
TR200401793T4 (tr) Perindopril tuzu ve bunu içeren farmasötik bileşimler.
SE0302573D0 (sv) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
DE602005025767D1 (de) Orale tedisamilformulierungen mit magenretentionseigenschaften und verzögerter freisetzung
CA2415154A1 (en) Modified release formulations of selective serotonin re-uptake inhibitors
HUP0302431A2 (hu) Diclofenac-tartalmú tapasz
SE0302572D0 (sv) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
DK1300143T3 (da) Plaster som indeholder 4-biphenyleddikesyre
EP1072261A3 (de) Felbinac enthaltendes Pflaster
BG66111B1 (bg) Галенова форма за орално приложение с продължително освобождаване на молсидомин
SE9901773D0 (sv) Förebyggande av karies i tänderna

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties